Mediclinic City Hospital and Mediclinic Parkview Hospital achieve Center of Excellence Accreditation in Endoscopy
Mediclinic Middle East is proud to announce that both Mediclinic City Hospital and Mediclinic Parkview Hospital have been recognised as Centres of Excellence (COE) in Endoscopy by the Surgical Review Corporation (SRC). This international recognition reflects the hospitals' unwavering commitment to delivering world-class patient care, advanced medical expertise, and excellence in endoscopic procedures.
The COE accreditation is granted to healthcare institutions that meet rigourous standards in patient safety, clinical quality, and innovative practices in endoscopy. It highlights highly trained specialists, state-of-the-art technology, and a continuous dedication to improving patient outcomes.
"We are honoured to receive this designation for two of our facilities, it underscores our dedication to providing the highest standards of endoscopic care," said Dr Jacques Kobersy, chief medical officer, Mediclinic Middle East. "This achievement reflects the expertise of our medical teams and our commitment to patient safety, precision diagnostics, and cutting-edge treatment options."
Endoscopic procedures play a crucial role in diagnosing and treating a wide range of medical conditions with minimally invasive techniques that promote faster recovery and improved patient experiences. The SRC accreditation assures patients that Mediclinic City Hospital and Mediclinic Parkview Hospital adhere to the highest levels of excellence in this field.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
an hour ago
- Zawya
Oman to produce medical diagnostic machines locally
A strategic Memorandum of Understanding (MoU) was signed by Dr Mohammad Mahmoodi, CEO of Carbon Technologies, and Dr Frank Vitzthum, Board Member and CTO of R-Biopharm, Germany, in the presence of Dr Rahma bint Ibrahim al Mahrouqiyah, Minister of Higher Education, Research and Innovation, on Tuesday. Under the MoU, advanced diagnostic manufacturing will be localised in Oman, supporting technology transfer and enhancing the country's health innovation ecosystem. The partnership will enable integration of state-of-the-art assay technologies into its local production lines, supporting both national and regional healthcare priorities. 'It is a milestone MoU in Oman's journey towards eliminating tuberculosis and other diseases from the country, and both communicable diseases and NCDs,' said Dr Rahma bint Ibrahim al Mahrouqiyah, Minister of Higher Education, Research and Innovation. 'I'm optimistic and this will pave the way for various scientific advancements in the country, especially when it is located near SQU and within the Innovation Park Muscat. We have begun, and we look forward to having an international consortium to eradicate both communicable and non-communicable diseases. We look forward to collaborating with regional, national and international partners so that we can cooperate with the leading players,' she added. Speaking to the Observer, Dr Mohammad Mahmoudi, Chief Executive Officer of Carbon Technologies, said that this collaboration is a testament to Oman's growing capacity in innovation-driven industries and its strategic openness to global partnerships. 'Together with R-Biopharm, we aim to elevate diagnostic standards, nurture Omani talent and contribute to national healthcare resilience,' Dr Mohammad added. Aligned with the objectives of Oman Vision 2040, the MoU supports national goals in biotechnology, scientific research and industrial innovation. Speaking on the sidelines of the signing ceremony, Eng Said bin Nasser al Salmi, Board Member of Carbon Technologies, said that the MoU would open up more opportunities to leverage Carbon Technologies as a leading Omani company and expand local R&D capabilities to serve both domestic and international markets in the healthcare industry and position Oman among the leading innovation hubs in such sectors. Dr Dirk Dressler, Head of Business Development at R-Biopharm AG, said, 'We are honoured to partner with Oman's Carbon Technologies. This collaboration reflects our confidence in Oman's capabilities and our shared commitment to delivering high-quality, accessible diagnostics across the region." 2025 © All right reserved for Oman Establishment for Press, Publication and Advertising (OEPPA) Provided by SyndiGate Media Inc. (
Khaleej Times
2 hours ago
- Khaleej Times
NMC Healthcare hosts 3-day series supporting MOHAP's Hayat initiative for World Organ Donation Day
This initiative aims to raise public awareness about the critical importance of organ donation and encourage organ donor registrations in the UAE NMC Healthcare ('NMC') is proud to host three days of educational sessions on organ donation, starting today, 13 August 2025, in observance of World Organ Donation Day. This initiative aims to raise public awareness about the critical importance of organ donation and encourage organ donor registrations in the UAE. The educational sessions are open to the public and will take place at five of NMC Healthcare's major hospitals in Sharjah, Dubai, and Abu Dhabi. The campaign is organised in collaboration with Hayat - the UAE's National Program for Donation and Transplantation of Human Organs and Tissues, led by the UAE's Ministry of Health & Prevention ('MOHAP'), which encourages UAE residents over the age of 18 to register as organ donors. Hayat follows international standards and best practices to promote safe and effective organ donation. Dr. Zaka ullah Khan, chief clinical officer at NMC Healthcare said: 'We are honoured to join forces with Hayat to bring attention to organ donation and share information about how organ donation transforms lives – from patients with chronic kidney failure, to those awaiting liver, heart, or lung transplants. We hope to help inspire more people to contribute to this life-saving cause.' NMC hospitals across the country will host a series of educational sessions which explain: NMC Healthcare encourages eligible individuals to learn more about organ donation and consider registering as donors through this life-saving campaign. For more information and to register as an organ donor, please visit the organ donation booths from 13-15 August, 2025, between 8:00am – 5:00pm at:
Emirates 24/7
4 hours ago
- Emirates 24/7
Al Jalila Foundation Supports 60 Organ Transplant Patients
Al Jalila Foundation, the philanthropic arm of Dubai Health, announced that it has contributed to saving the lives of 60 patients by supporting organ transplant surgeries as part of the first and second editions of the Your Donation Saves Lives campaign. The announcement coincides with World Organ Donation Day, observed annually on 13 August, and reflects the Foundation's long-term commitment to supporting patients with organ failure and fostering a culture of organ donation as a humanitarian value. Since its launch in April 2021, the campaign has supported 60 transplant procedures, including 53 kidney transplants and 7 liver transplants. Among these are 24 children with kidney failure and 5 children with liver failure. As part of this program, the Foundation continues to support more than 65 patients with life-saving transplants, who are unable to access or afford specialized care. These efforts are aligned with the goals of HAYAT, the National Program for Organ and Tissue Donation and Transplantation and are carried out in partnership with Dubai Health's integrated academic health system. From Campaign to Permanent Program Dr. Amer Al Zarooni, CEO of Al Jalila Foundation, announced that the Your Donation Saves Lives campaign has now evolved into a permanent initiative under the Foundation's A'awen program, which provides financial assistance to patients in need of critical medical treatment across the UAE, a step that aligns with Dubai Health's commitment, 'Patient First'. 'On World Organ Donation Day, we reaffirm our commitment to supporting patients with organ failure and extend our heartfelt thanks to the generous donors, individuals and institutions alike, who contributed to both the first and second editions of the Your Donation Saves Lives campaign. Their support represents a powerful model of human solidarity, with the first edition alone helping to fund nearly 30% of all organ transplants performed in Dubai,' said Dr. Al Zarooni. He also extended his appreciation to living organ donors and to the families of deceased donors, saying: 'Your compassion has given others a second chance at life. We thank you for your extraordinary generosity.' Ensuring Safe, Successful Transplants Dr. Ashraf Al Hinnawi, Consultant Transplant Surgeon at Dubai Health, explained that the medical team works collaboratively to thoroughly evaluate both the donor and the recipient before transplantation, ensuring the highest possible long-term success rates. 'We conduct comprehensive assessments of kidney function and immune compatibility between the donor and recipient, along with detailed medical and surgical evaluations that include lab tests and imaging studies to ensure the success of the transplant. We also follow up with patients regularly after the procedure to ensure adherence to the treatment plan and to closely monitor kidney function.' Regarding living donors, Dr. Al Hinnawi noted that they undergo meticulous evaluations, including assessment of the kidneys, functional testing, and screening for any infectious or cancerous conditions, in addition to psychological and social assessments. He added that all cases are reviewed by a multidisciplinary medical committee to determine donor eligibility, ensuring the highest levels of safety for both donor and recipient. A Lifeline for Patients in Need Al Jalila Foundation continues to welcome donations through A'awen, offering individuals and organizations the opportunity to fund life-changing programs that enhance well-being and provide essential medical care. The first edition of the campaign was launched in April 2021 in collaboration with Mohammed Bin Rashid University of Medicine and Health Sciences, the Islamic Affairs and Charitable Activities Department, and Emarat Al Youm newspaper. The second edition took place in September 2024 and concluded in December of the same year, as part of a collaboration between the Islamic Affairs and Charitable Activities Department, Al Jalila Foundation, and Emarat Al Youm newspaper. Transplant surgeries were conducted in partnership with Dubai Health's Dubai Hospital and Al Jalila Children's Hospital, alongside Mediclinic City Hospital and King's College Hospital London in Dubai. Stories of Hope Yousef's New Beginning Among the beneficiaries of the campaign, is the child Yousef Jashim, who underwent a kidney transplant with the support of Al Jalila Foundation. Yousef suffered from constant fatigue and recurring pain and was undergoing regular dialysis sessions that significantly affected his daily life and imposed strict dietary restrictions. When he turned fourteen, the doctors informed his family of the necessity of a kidney transplant as an essential step in his treatment journey. Al Jalila Foundation's support was instrumental, helping the family cover the cost of the surgery. Following the transplant, Yousef's life transformed. He regained his energy and no longer required dialysis. His mother expressed deep gratitude to Al Jalila Foundation, the medical teams involved in his care, and the wider community whose support helped save her son's life. Roula's Healing Journey Roula Tabba'a is also among the beneficiaries of the campaign, following a long journey with kidney failure. She underwent dialysis three times a week, which caused severe physical and emotional exhaustion. Her condition was first diagnosed in 2016, and she underwent several surgeries. Al Jalila Foundation covered the cost of her dialysis sessions and medical tests, eventually supporting her inclusion in the kidney transplant program. After years of waiting, Roula received a life-changing call from the medical team confirming that she had been approved for the procedure. Thanks to the dedication of the medical staff, the transplant was successful. Her life was completely transformed following the surgery, she no longer needed dialysis and regained her ability to move freely, travel, and live independently. Roula expressed her deep gratitude to Al Jalila Foundation, saying its support not only saved her life, but also restored hope and stability for her entire family.
